• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术前超高水平的血清完整甲状旁腺激素和骨转换标志物随移植肾功能恢复及短期大剂量甲基强的松龙治疗而下降:一项回顾性队列研究

Super-high levels of serum intact-parathyroid hormone and bone turnover markers descended with recuperating allograft function and a short-term high-dose methylprednisolone during preoperative period of renal transplantation: a retrospective cohort study.

作者信息

Xie Wenqing, Lv Junhao, Wei Chuncun, He Zhechi, Wang Suya

机构信息

Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.

Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, China.

出版信息

Transl Androl Urol. 2025 Feb 28;14(2):402-411. doi: 10.21037/tau-24-398. Epub 2025 Feb 25.

DOI:10.21037/tau-24-398
PMID:40114826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11921216/
Abstract

BACKGROUND

Secondary hyperparathyroidism is an important factor of chronic kidney disease-mineral and bone disorder (CKD-MBD), which frequently results in maintenance dialysis patients having super-high levels of serum intact-parathyroid hormone (iPTH) and bone turnover markers (BTMs). This study aimed to investigate the immediate changes of iPTH and BTMs levels after renal transplantation during the perioperative period, and to explore the allograft function rapid recovery and the effect of high-dose glucocorticoids on serum iPTH and BTMs.

METHODS

Between April 2018 and August 2021, a total of 346 Chinese kidney transplantation (KT) recipients (median age, 34.0 years; 236 males and 110 females; median dialysis duration, 12 months) were enrolled in this retrospective cohort study. The included patients had been undergoing maintenance dialysis for at least three months before transplant, and all of them accepted short-term high-dose methylprednisolone (MP) to prevent allograft rejection in the perioperative period. Allograft functions were evaluated and divided into different groups accorded to the CKD staging on the postoperative fifth day. Serum beta C-terminal crosslinking telopeptide of type I collagen (β-CTX), type 1N-terminal propeptide (P1NP), osteocalcin (OC), and iPTH were measured from fasting morning blood samples before surgery and on the postoperative fifth day with an electro-chemiluminescence immunoassay analyzer (2012; Roche Diagnostics).

RESULTS

Among the participants, the graft functions were in CKD-II (n=134), CKD-III (n=137), CKD-IV (n=24), and CKD-V (n=51) after the postoperative fifth day. The changes of P1NP level [-95.8 (-84.0 to -2.4) ng/mL] and the OC level [-88.0 (-96.9 to -42.9) ng/mL] were significantly greater than those of the β-CTX level [-62.3 (-73.6 to 0) pg/mL] and the iPTH level [-57.6 (-15.6 to 11.9) pg/mL] (P<0.001). In the CKD-V group, the changes of β-CTX level [-0.7 (-43.15 to 0) pg/mL (+15.7%, P=0.61)] and the iPTH level [-8.69 (226.73 to 17.79) pg/mL (-22.8%), P=0.36] were less than those of the CKD-II group (P<0.001). β-CTX, P1NP, and OC levels related with iPTH (r=0.413, 0.459, 0.482, respectively, P<0.001), and iPTH level with estimated glomerular filtration rate (eGFR; r=-0.474, P<0.001).

CONCLUSIONS

The super-high levels of BTMs and iPTH rapidly descended with recuperating allograft function during the short-term, indicating that improvement of current dialysis equipment to achieve clean up iPTH could more favorably decrease BMTs and improve CKD-MBD. Osteogenesis markers P1NP and OC still decreased and were not affected in CKD-V group, indicating that high-dose glucocorticoids might strongly inhibit osteoblast activity.

摘要

背景

继发性甲状旁腺功能亢进是慢性肾脏病 - 矿物质和骨异常(CKD - MBD)的一个重要因素,这经常导致维持性透析患者血清全段甲状旁腺激素(iPTH)和骨转换标志物(BTMs)水平超高。本研究旨在调查肾移植围手术期肾移植后iPTH和BTMs水平的即刻变化,并探讨移植肾功能的快速恢复以及大剂量糖皮质激素对血清iPTH和BTMs的影响。

方法

在2018年4月至2021年8月期间,共有346例中国肾移植(KT)受者(中位年龄34.0岁;男性236例,女性110例;中位透析时间12个月)纳入这项回顾性队列研究。纳入的患者在移植前已接受维持性透析至少三个月,并且他们所有人在围手术期均接受短期大剂量甲泼尼龙(MP)以预防移植排斥反应。根据术后第五天的CKD分期评估移植肾功能并将其分为不同组。术前及术后第五天清晨空腹血样采用电化学发光免疫分析仪(2012;罗氏诊断)检测血清I型胶原βC末端交联肽(β - CTX)、I型前胶原N端前肽(P1NP)、骨钙素(OC)和iPTH。

结果

参与者中,术后第五天移植肾功能处于CKD - II期(n = 134)、CKD - III期(n = 137)、CKD - IV期(n = 24)和CKD - V期(n = 51)。P1NP水平的变化[-95.8(-84.0至-2.4)ng/mL]和OC水平的变化[-88.0(-96.9至-42.9)ng/mL]显著大于β - CTX水平的变化[-62.3(-73.6至0)pg/mL]和iPTH水平的变化[-57.6(-15.6至11.9)pg/mL](P < 0.001)。在CKD - V组中,β - CTX水平的变化[-0.7(-43.15至0)pg/mL(+15.7%,P = 0.61)]和iPTH水平的变化[-8.69(226.73至17.79)pg/mL(-22.8%),P = 0.36]小于CKD - II组(P < 0.001)。β - CTX、P1NP和OC水平与iPTH相关(r分别为0.413、0.459、0.482,P < 0.001),iPTH水平与估计肾小球滤过率(eGFR;r = -0.474,P < 0.001)相关。

结论

在短期内,随着移植肾功能的恢复,超高水平的BTMs和iPTH迅速下降,这表明改进当前的透析设备以清除iPTH可能更有利于降低BMTs并改善CKD - MBD。成骨标志物P1NP和OC在CKD - V组中仍下降且未受影响,表明大剂量糖皮质激素可能强烈抑制成骨细胞活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909c/11921216/51dfa01be968/tau-14-02-402-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909c/11921216/51dfa01be968/tau-14-02-402-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/909c/11921216/51dfa01be968/tau-14-02-402-f1.jpg

相似文献

1
Super-high levels of serum intact-parathyroid hormone and bone turnover markers descended with recuperating allograft function and a short-term high-dose methylprednisolone during preoperative period of renal transplantation: a retrospective cohort study.肾移植术前超高水平的血清完整甲状旁腺激素和骨转换标志物随移植肾功能恢复及短期大剂量甲基强的松龙治疗而下降:一项回顾性队列研究
Transl Androl Urol. 2025 Feb 28;14(2):402-411. doi: 10.21037/tau-24-398. Epub 2025 Feb 25.
2
The levels of bone turnover markers and parathyroid hormone and their relationship in chronic kidney disease.慢性肾脏病患者骨转换标志物和甲状旁腺激素水平及其相关性。
Clin Chim Acta. 2023 Aug 1;548:117518. doi: 10.1016/j.cca.2023.117518. Epub 2023 Aug 22.
3
Mineral and bone disorder after kidney transplantation: a single-center cohort study.肾移植后矿物质和骨代谢紊乱:单中心队列研究。
Ren Fail. 2023 Dec;45(1):2210231. doi: 10.1080/0886022X.2023.2210231.
4
Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.中国晚期慢性肾脏病患者的碱性磷酸酶、甲状旁腺激素及骨转换标志物
Clin Lab. 2015;61(7):839-43. doi: 10.7754/clin.lab.2015.141101.
5
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.维持性血液透析患者中FGF23与骨代谢标志物的相关性及时间进程
Clin Biochem. 2014 Sep;47(13-14):1316-9. doi: 10.1016/j.clinbiochem.2014.06.009. Epub 2014 Jun 21.
6
Impact of treatment with active vitamin D calcitriol on bone turnover markers in people with type 2 diabetes and stage 3 chronic kidney disease.活性维生素 D 骨化三醇治疗对 2 型糖尿病和 3 期慢性肾脏病患者骨转换标志物的影响。
Bone. 2023 Jan;166:116581. doi: 10.1016/j.bone.2022.116581. Epub 2022 Oct 8.
7
Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients.基质金属蛋白酶-1和-2作为慢性肾病患者矿物质骨病的标志物。
Hippokratia. 2017 Jan-Mar;21(1):25-31.
8
Bone turnover markers reference database in five Southeast Asian countries.五个东南亚国家的骨转换标志物参考数据库。
Bone. 2024 Oct;187:117182. doi: 10.1016/j.bone.2024.117182. Epub 2024 Jun 28.
9
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients.缓释骨化二醇持续降低升高的全段甲状旁腺激素浓度可减缓继发性甲状旁腺功能亢进患者的慢性肾脏病进展。
Am J Nephrol. 2024 Aug 27:1-10. doi: 10.1159/000541138.
10
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.透析治疗的慢性肾脏病患者骨转换标志物和骨组织学的诊断准确性。
Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.

本文引用的文献

1
Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management.肾移植受者移植后骨病:诊断与管理。
Int J Mol Sci. 2024 Feb 3;25(3):1859. doi: 10.3390/ijms25031859.
2
Long-term effects of hypercalcemia in kidney transplant recipients with persistent hyperparathyroidism.持续性甲状旁腺功能亢进的肾移植受者高钙血症的长期影响。
J Nephrol. 2024 Jul;37(6):1497-1507. doi: 10.1007/s40620-023-01815-5. Epub 2023 Nov 30.
3
Associations of Changes in Bone Turnover Markers with Change in Bone Mineral Density in Kidney Transplant Patients.
肾移植患者骨转换标志物变化与骨密度变化的相关性
Clin J Am Soc Nephrol. 2024 Apr 1;19(4):483-493. doi: 10.2215/CJN.0000000000000368. Epub 2023 Nov 29.
4
A clinical study of using ROC to compare the efficiency of ASL and BOLD in diagnosis of renal allograft function.一项使用ROC比较动脉自旋标记(ASL)和血氧水平依赖性功能磁共振成像(BOLD)诊断肾移植功能效率的临床研究。
Transl Androl Urol. 2023 Apr 28;12(4):612-621. doi: 10.21037/tau-23-136. Epub 2023 Apr 17.
5
Chronic kidney disease mineral and bone disorder: A guide for general practice.慢性肾脏病矿物质和骨异常:全科医学指南。
Aust J Gen Pract. 2023 Jan-Feb;52(1-2):52-57. doi: 10.31128/AJGP-03-22-6365.
6
Regional delivery of immunosuppression for transplantation of vascularized composite allografts: opportunities near and far.血管化复合组织异体移植中免疫抑制的区域递送:远近机遇
Ann Transl Med. 2021 Nov;9(22):1635. doi: 10.21037/atm-2021-15.
7
Bone mineral density and mortality in end-stage renal disease patients.终末期肾病患者的骨矿物质密度与死亡率
Clin Kidney J. 2020 Jun 26;13(3):307-321. doi: 10.1093/ckj/sfaa089. eCollection 2020 Jun.
8
Behavior of Bone Mineral Metabolism in Renal Posttransplantation Patients with Severe Hyperparathyroidism.肾移植术后严重甲状旁腺功能亢进患者的骨矿物质代谢行为
Transplant Proc. 2020 May;52(4):1143-1146. doi: 10.1016/j.transproceed.2020.01.055. Epub 2020 Apr 8.
9
Mineral bone disorder and osteoporosis in hemodialysis patients.血液透析患者的矿物质骨代谢紊乱与骨质疏松症
Adv Rheumatol. 2020 Feb 26;60(1):15. doi: 10.1186/s42358-020-0118-0.
10
Mechanism of Methylprednisolone-Induced Primary Cilia Formation Disorder and Autophagy in Osteoblasts.甲泼尼龙诱导成骨细胞原发性纤毛形成障碍和自噬的机制。
Orthop Surg. 2020 Apr;12(2):645-652. doi: 10.1111/os.12630. Epub 2020 Feb 16.